Xinyue Qi recently joined the Virology Biostatistics team as Manager, Biostatistics in Clinical Data Science at Gilead Sciences. Xinyue came from Incyte Corporation, where she started out as Principal Biostatistician focusing on phase II oncology/hematology clinical studies across multiple indications with regulatory submission experiences.
Prior to Incyte, she was a Graduate Research Assistant at the University of Texas MD Anderson Cancer Center (MD Anderson) and completed her doctoral degree in Biostatistics at the University of Texas Health Science Center at Houston under the supervision of Dr. Shouhao Zhou in the Department of Public Health Sciences at Penn State College of Medicine and Dr. Christine B. Peterson in the Department of Biostatistics at MD Anderson. She graduated from School of Medicine at Duke University with a master’s degree in Biostatistics and University of Illinois at Urbana-Champaign with a bachelor’s degree in Molecular and Cellular Biology.
Her research interests span the topics of Bayesian modeling for censored data, (network) meta-analysis with applications to cancer immunotherapies, and evaluating the safety & efficacy of treamtent options in patients with hematological malignancies.